Cabaletta Bio Statistics
Total Valuation
Cabaletta Bio has a market cap or net worth of $195.39 million. The enterprise value is -$430,308.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, before market open.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Cabaletta Bio has 48.85 million shares outstanding. The number of shares has increased by 40.14% in one year.
| Current Share Class | 48.85M |
| Shares Outstanding | 48.85M |
| Shares Change (YoY) | +40.14% |
| Shares Change (QoQ) | +0.29% |
| Owned by Insiders (%) | 3.10% |
| Owned by Institutions (%) | 92.85% |
| Float | 41.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.97 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.52, with a Debt / Equity ratio of 0.04.
| Current Ratio | 11.52 |
| Quick Ratio | 11.35 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -48.16% and return on invested capital (ROIC) is -32.49%.
| Return on Equity (ROE) | -48.16% |
| Return on Assets (ROA) | -31.13% |
| Return on Capital (ROIC) | -32.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$873,621 |
| Employee Count | 103 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.00% in the last 52 weeks. The beta is 2.42, so Cabaletta Bio's price volatility has been higher than the market average.
| Beta (5Y) | 2.42 |
| 52-Week Price Change | -75.00% |
| 50-Day Moving Average | 4.44 |
| 200-Day Moving Average | 11.37 |
| Relative Strength Index (RSI) | 46.23 |
| Average Volume (20 Days) | 933,654 |
Short Selling Information
The latest short interest is 3.78 million, so 7.74% of the outstanding shares have been sold short.
| Short Interest | 3.78M |
| Short Previous Month | 5.32M |
| Short % of Shares Out | 7.74% |
| Short % of Float | 9.15% |
| Short Ratio (days to cover) | 3.86 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -100.12M |
| Pretax Income | -89.98M |
| Net Income | -89.98M |
| EBITDA | -98.61M |
| EBIT | -100.12M |
| Earnings Per Share (EPS) | -$1.92 |
Full Income StatementBalance Sheet
The company has $203.23 million in cash and $7.40 million in debt, giving a net cash position of $195.83 million or $4.01 per share.
| Cash & Cash Equivalents | 203.23M |
| Total Debt | 7.40M |
| Net Cash | 195.83M |
| Net Cash Per Share | $4.01 |
| Equity (Book Value) | 199.52M |
| Book Value Per Share | 4.13 |
| Working Capital | 188.36M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$73.83 million and capital expenditures -$1.83 million, giving a free cash flow of -$75.66 million.
| Operating Cash Flow | -73.83M |
| Capital Expenditures | -1.83M |
| Free Cash Flow | -75.66M |
| FCF Per Share | -$1.55 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |